Sol-Gel Technologies (SLGL) Assets Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Sol-Gel Technologies | 205.76 Mn | 194.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.54% |
| Sep 30, 2025 | -19.52% |
| Jun 30, 2025 | -6.42% |
| Mar 31, 2025 | -32.19% |
| Dec 31, 2024 | -20.85% |
| Sep 30, 2024 | -13.80% |
| Jun 30, 2024 | -23.77% |
| Mar 31, 2024 | -18.62% |
| Dec 31, 2023 | -2.88% |
| Sep 30, 2023 | -2.78% |
| Jun 30, 2023 | 0.22% |
| Mar 31, 2023 | -12.51% |
| Dec 31, 2022 | -32.61% |
| Sep 30, 2022 | -2.91% |
| Jun 30, 2022 | 18.49% |
| Mar 31, 2022 | 4.56% |
| Dec 31, 2021 | 16.95% |
| Sep 30, 2021 | -20.37% |
| Jun 30, 2021 | -37.82% |
| Mar 31, 2021 | -30.21% |
| Dec 31, 2020 | -3.49% |
| Sep 30, 2020 | -2.27% |
| Jun 30, 2020 | 17.76% |
| Mar 31, 2020 | 12.98% |
| Dec 31, 2019 | -12.03% |
| Sep 30, 2019 | -15.83% |
| Jun 30, 2019 | -26.61% |
| Mar 31, 2019 | -24.40% |
| Dec 31, 2018 | 354.99% |
| Dec 31, 2017 | 39.42% |